Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Kidney Journal|May 13, 2021
Exercise training in chronic kidney disease-effects, expectations and adherenceNaomi Clyne, Kirsten Anding-Rost
European Journal of Preventive Cardiology|April 9, 2024
The role of exercise training on cardiovascular risk factors and heart disease in patients with chronic kidney disease G3-G5 and G5D: a Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESC and the European Association of Rehabilitation in Chronic Kidney DiseaseEvangelia Kouidi, Henner Hanssen, Kirsten Anding-Rost, et al.
NEJM Evidence|February 6, 2024
Exercise during Hemodialysis in Patients with Chronic Kidney FailureKirsten Anding-Rost, Gero von Gersdorff, Pia von Korn, et al.
Methods and Protocols|September 26, 2021
Cluster Randomized Controlled Trial on the Effects of 12 Months of Combined Exercise Training during Hemodialysis in Patients with Chronic Kidney Disease-Study Protocol of the Dialysis Training Therapy (DiaTT) TrialGero von Gersdorff, Pia von Korn, André Duvinage, et al.
Vaccines|July 27, 2024
Hybrid Immunity Protects against Antibody Fading after SARS-CoV-2mRNA Vaccination in Kidney Transplant Recipients, Dialysis Patients, and Medical Personnel: 9 Months Data from the Prospective, Observational Dia-Vacc StudyJulian Stumpf, Torsten Siepmann, Jörg Schwöbel, et al.
Vaccine|December 19, 2023
9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patientsJulian Stumpf, Leona Anders, Torsten Siepmann, et al.
The Lancet Regional Health. Europe|April 18, 2022
Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc studyJulian Stumpf, Jörg Schwöbel, Tom Lindner, et al.
The Lancet Regional Health. Europe|July 28, 2021
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccineJulian Stumpf, Torsten Siepmann, Tom Lindner, et al.
Pageof 1